Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Cytokeratin 17 Mouse anti-Human, Clone: KRT17/4604, Novus Biologicals™

Cytokeratin 17 Mouse anti-Human, Clone: KRT17/4604, Novus Biologicals™
SDP

Catalog No. NB122838 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
20 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB122838 20 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB122838 Supplier Novus Biologicals Supplier No. NBP30768220UG
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Cytokeratin 17 Monoclonal specifically detects Cytokeratin 17 in Human samples. It is validated for Immunohistochemistry-Paraffin.

Specifications

Antigen Cytokeratin 17
Applications Immunohistochemistry (Paraffin)
Classification Monoclonal
Clone KRT17/4604
Concentration 0.2 mg/ml
Conjugate Unconjugated
Dilution Immunohistochemistry-Paraffin 1-2 ug/ml
Formulation 10 mM PBS with 0.05% BSA
Gene Alias 39.1, CK-17, cytokeratin-17, K17, keratin 17, keratin, type I cytoskeletal 17, keratin-17, PC, PC2, PCHC1
Host Species Mouse
Immunogen Recombinant full-length human Cytokeratin 17 protein
Purification Method Protein A or G purified
Quantity 20 μg
Regulatory Status RUO
Research Discipline Cancer
Primary or Secondary Primary
Gene ID (Entrez) 3872
Target Species Human
Content And Storage Store at 4°C.
Form Purified
Isotype IgG1 κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.